Figure 3

Correlation between the disulfidptosis-related signature and clinicopathological features. (A) The KM survival plots showed the survival probability of the disulfidptosis-related signature risk score and OS of GBM and LGG respectively. (B) The beeswarm plot showed the difference of risk scores between GBM and LGG patients in all four datasets. (C) The boxplot showed the difference of risk scores between IDH wildtype (WT) and mutant, MGMT promoter unmethylated and methylated, 1p19q non-codeletion and codeletion patients from TCGA dataset. (D) The boxplot showed the difference of risk scores between IDH wildtype and mutant, 1p19q non-codeletion and codeletion patients from CGGA dataset. ***p < 0.001.